Donaldson Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.4M Buy
785,160
+7,199
+0.9% +$831K 3.06% 10
2025
Q4
$81.9M Sell
777,961
-8,922
-1% -$838K 2.6% 11
2025
Q3
$66M Buy
786,883
+313,652
+66% +$25.8M 2.09% 14
2025
Q2
$37.5M Sell
473,231
-2,547
-0.5% -$202K 1.38% 28
2025
Q1
$42.7M Buy
475,778
+6,027
+1% +$563K 1.61% 28
2024
Q4
$46.7M Sell
469,751
-5,182
-1% -$534K 1.78% 24
2024
Q3
$53.9M Sell
474,933
-12,457
-3% -$1.48M 2.07% 20
2024
Q2
$60.3M Buy
487,390
+10,017
+2% +$1.29M 2.53% 14
2024
Q1
$63M Buy
477,373
+6,292
+1% +$776K 2.62% 12
2023
Q4
$51.4M Sell
471,081
-8,773
-2% -$911K 2.3% 18
2023
Q3
$49.4M Buy
479,854
+6,710
+1% +$723K 2.33% 15
2023
Q2
$54.6M Sell
473,144
-87
-0% -$9.88K 2.49% 14
2023
Q1
$50.3M Sell
473,231
-170,069
-26% -$18.4M 2.38% 15
2022
Q4
$71.4M Buy
643,300
+18,512
+3% +$1.89M 3.48% 5
2022
Q3
$53.8M Buy
624,788
+16,175
+3% +$1.44M 2.95% 11
2022
Q2
$55.5M Sell
608,613
-46,521
-7% -$4.12M 2.86% 10
2022
Q1
$53.8M Buy
655,134
+18,935
+3% +$1.49M 2.45% 14
2021
Q4
$48.8M Buy
636,199
+30,526
+5% +$2.43M 2.14% 17
2021
Q3
$45.5M Buy
605,673
+222,078
+58% +$16.9M 2.29% 19
2021
Q2
$29.8M Buy
383,595
+23,582
+7% +$1.75M 1.53% 24
2021
Q1
$26.5M Buy
360,013
+44,961
+14% +$3.32M 1.46% 26
2020
Q4
$24.6M Buy
315,052
+308,654
+4,824% +$23.6M 1.46% 28
2020
Q3
$506K Sell
6,398
-740
-10% -$58K 0.03% 142
2020
Q2
$527K Buy
7,138
+78
+1% +$5.87K 0.04% 127
2020
Q1
$518K Sell
7,060
-27,310
-79% -$2.15M 0.05% 110
2019
Q4
$2.98M Buy
34,370
+450
+1% +$37K 0.2% 66
2019
Q3
$2.73M Buy
33,920
+344
+1% +$27.6K 0.2% 67
2019
Q2
$2.69M Sell
33,576
-1,371
-4% -$105K 0.22% 57
2019
Q1
$2.77M Buy
34,947
+1,373
+4% +$103K 0.25% 52
2018
Q4
$2.45M Buy
33,574
+806
+2% +$56.9K 0.25% 53
2018
Q3
$2.22M Buy
32,768
+773
+2% +$49.2K 0.19% 60
2018
Q2
$1.85M Sell
31,995
-846
-3% -$47.7K 0.18% 62
2018
Q1
$1.71M Sell
32,841
-303
-0.9% -$16.4K 0.17% 67
2017
Q4
$1.78M Sell
33,144
-615
-2% -$34.1K 0.17% 69
2017
Q3
$2.06M Buy
33,759
+27,166
+412% +$1.65M 0.22% 62
2017
Q2
$403K Sell
6,593
-670
-9% -$40.8K 0.05% 111
2017
Q1
$440K Buy
7,263
+1,538
+27% +$93.3K 0.05% 105
2016
Q4
$322K Sell
5,725
-10
-0.2% -$585 0.04% 117
2016
Q3
$341K Buy
5,735
+543
+10% +$31.8K 0.05% 110
2016
Q2
$285K Buy
5,192
+384
+8% +$20.4K 0.04% 124
2016
Q1
$243K Sell
4,808
-3,154
-40% -$154K 0.04% 130
2015
Q4
$401K Buy
7,962
+1,681
+27% +$84.8K 0.06% 101
2015
Q3
$296K Buy
6,281
+236
+4% +$12.5K 0.04% 114
2015
Q2
$328K Sell
6,045
-1,205
-17% -$67.6K 0.05% 113
2015
Q1
$398K Buy
7,250
+1,301
+22% +$73.7K 0.06% 103
2014
Q4
$322K Buy
5,949
+648
+12% +$36.1K 0.05% 114
2014
Q3
$300K Sell
5,301
-297
-5% -$16.7K 0.05% 109
2014
Q2
$309K Sell
5,598
-288
-5% -$15.7K 0.05% 108
2014
Q1
$319K Buy
5,886
+158
+3% +$8.18K 0.06% 90
2013
Q4
$274K Buy
5,728
+1,162
+25% +$53.1K 0.05% 87
2013
Q3
$207K Sell
4,566
-53
-1% -$2.42K 0.04% 96
2013
Q2
$205K Buy
+4,619
New +$206K 0.05% 92

Other funds holding MRK

Donaldson Capital Management's MRK Position: Q1 2026 in Review

Donaldson Capital Management increased its Merck (MRK) stake by 0.93% in Q1 2026, buying an estimated $831K and bringing the position to 785,160 shares worth $94.4M. The position accounts for 3.06% of the portfolio, ranked #10.

Donaldson Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Donaldson Capital Management held 785,160 shares of Merck worth $94.4M as of Q1 2026.
  • Donaldson Capital Management bought 7,199 Merck shares in Q1 2026, an estimated $831K.
  • Merck made up 3.06% of Donaldson Capital Management's portfolio in Q1 2026, its #10 holding.
  • Donaldson Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.